Disclaimer: The information, documents and graphic depictions (the "Information") published on this Web site are the property of LIfT BioSciences Ltd. LIfT BioSciences assumes no responsibility for errors or omissions in the Information on this website. In no event shall LIfT BioSciences be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of this Web site or the Information. LIfT BioSciences reserves the right to make additions, deletions, or modification to the Information on the Web site at any time without prior notice.

  • CEO's Linked-in
  • CEO's Twitter
  • LIfTBio on Facebook

©2016 LIfT BioSciences Ltd

 

We are committed to Developing The World's First Cell Therapy to Destroy All Solid Tumours, irrespective of strain or mutation. We are achieving this by building The World's 1st Cell Bank of Innately Cancer Killing Neutrophils.

 

Our 1st Mission is to show remission in high unmet need solid tumours by 2021,

including Pancreatic Cancer.

 

Proudly Supported by / Partnered with: